↓ Skip to main content

Managing adverse events of sacituzumab govitecan

Overview of attention for article published in Expert Opinion on Biological Therapy, October 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#30 of 1,989)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
46 X users

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Managing adverse events of sacituzumab govitecan
Published in
Expert Opinion on Biological Therapy, October 2023
DOI 10.1080/14712598.2023.2267975
Pubmed ID
Authors

Ilana Schlam, Paolo Tarantino, Sara M. Tolaney

X Demographics

X Demographics

The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 1 25%
Researcher 1 25%
Other 1 25%
Student > Doctoral Student 1 25%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 25%
Nursing and Health Professions 1 25%
Agricultural and Biological Sciences 1 25%
Chemistry 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2023.
All research outputs
#1,427,315
of 25,734,859 outputs
Outputs from Expert Opinion on Biological Therapy
#30
of 1,989 outputs
Outputs of similar age
#24,444
of 360,924 outputs
Outputs of similar age from Expert Opinion on Biological Therapy
#1
of 14 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,989 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.